PolyPid Competitors and Similar CompaniesClear all
PolyPid's competitors and similar companies include Metabolon and Meissa Vaccines.
 PolyPid PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API). |  Metabolon Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research. |  Meissa Vaccines Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus. | |
Founding Date | Founding Date 2008 | Founding Date 2000 | Founding Date 2014 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Petah Tikva, IL HQ Summit, US | Locations Morrisville, US HQ Hallbergmoos, DE München, DE | Locations South San Francisco, US HQ Redwood City, US |
Employees | Employees 57 | Employees 1911% increase | Employees 3 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 15m (over 9 years ago) | Latest funding round $ 30m (over 6 years ago) |
Total funding raised | Total funding raised $ 103.8m | Total funding raised $ 95.4m | Total funding raised $ 33.4m |
For sources of this data, please see the company profile
View Company Profiles
Metabolon
HQ
Morrisville, US
Employees
191↑ 1% increase
Global leader in metabolomics for precision medicine, biomarker discovery, and advancing pharma & life sciences research.
View companyMeissa Vaccines
HQ
South San Francisco, US
Employees
3
Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.
View company